Justin Delgado is husband to Kacie Doyle-Delgado, diagnosed at age 11. After more than a decade together, he considers himself to be an expert carb counter and Dexcom inserter. He graduated with his Master of Science in Finance from the University of Utah in 2013 and has been working in commercial banking since then. He attended his first Friends for Life conference in 2015 and is looking forward to volunteering with the teens.
October 13, 2005
Question from Cozad, Nebraska, USA:
My family doctor has just prescribed me the Byetta injectable pen. I had been taking metformin, Amaryl and Avandia for my type 2, but, recently, I determined that my severe diarrhea, which lasted for months, was from taking these medications. I conducted an experiment. If I didn't take them, I had no diarrhea. After a while, I went to our family doctor and told him. He prescribed the pen, two times daily, once before breakfast and once before my evening meal. I was wondering what you might know about this pen and it's successful use. I am to use the pen and stop all other diabetes medications. I am hopeful it will work, but I am a little concerned as the only injectables I know about are for insulin. I would appreciate another opinion.
There has been a lot of excitement over the introduction of Byetta for the treatment of type 2 diabetes. The medication is an analog (a drug that looks like another naturally occurring hormone) of glucaon-like peptide I (GLP-I). GLP-I is a naturally occurring hormone made in the gut and helps the body respond to ingested glucose. The hormone slows GI transit, induces a decrease in the anti-insulin hormone glucagon, and actually stimulates the pancreas to make insulin in response to ingested food. Therefore, its effects are more potent with the post-meal glucose than the fasting glucose. In testing these compounds, it also appears that Byetta helps to induce weight loss, an added benefit in patients with diabetes. In fact, in data recently presented at the Scientific Sessions of the American Diabetes Association this summer, Byetta was able to induce an average of 11 pounds of weight loss over the three years it was used in the trial. It appears the drug works through a central mechanism inducing satiety and decreased appetite. It has been approved by FDA for patients who fail to obtain good blood sugar control on metformin and/or sulfonylureas.
You were on three medications. The metformin is the most common cause of diarrhea among the drugs you were taking. In most of the trials, the oral medications were not stopped. You may want to talk to your physician about continuing at least the Amaryl. The medication has been used in a number of patients already. The biggest side effect has been nausea. However, the more we use it, the less of a deal this seems to be. Long-term, this also may be a medication that may prevent the loss of insulin secretory capacity and change the natural history of type 2 diabetes.